Open access · CC-BY
via OpenAlex
Targeting Telomere Shortening in Vascular Aging and Atherosclerosis: Therapeutic Promise of Astragalus membranaceus
Paola Canale, Maria Grazia Andreassi
Journal of Cardiovascular Development and Disease · 2025 · ▲ 4 citations
Abstract
Telomere(definition) dysfunction has emerged as a pivotal contributor to vascular senescence(definition), a fundamental process in the pathogenesis of age-related cardiovascular diseases such as atherosclerosis. This connection underscores the therapeutic potential of targeting telomere biology to prevent or mitigate the progression of vascular aging. In this context, Astragalus membranaceus and its bioactive constituents, including astragaloside IV, cycloastragenol, and the commercial telomerase activator TA-65, demonstrate significant promise in attenuating vascular aging and atherosclerotic disease. These compounds exert a range of pleiotropic effects, including anti-inflammatory, antioxidant, endothelial-protective, and lipid-modulating actions, while also modulating telomerase activity and supporting telomere maintenance. This review provides an overview of the mechanistic basis underlying the anti-atherosclerotic effects of Astragalus-derived compounds and underscores critical key knowledge gaps. It also outlines future research directions necessary to validate their efficacy and therapeutic potential in the prevention and treatment of atherosclerosis and other age-related vascular disorders.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/jcdd12090341
- Canonical
- link ↗
- Fetched
- 2026-10-04 MST
Cite this
APA
Canale, P., & Andreassi, M.G. (2025). Targeting Telomere Shortening in Vascular Aging and Atherosclerosis: Therapeutic Promise of Astragalus membranaceus. <em>Journal of Cardiovascular Development and Disease</em>. https://doi.org/10.3390/jcdd12090341
Vancouver
Canale P, Andreassi MG. Targeting Telomere Shortening in Vascular Aging and Atherosclerosis: Therapeutic Promise of Astragalus membranaceus. Journal of Cardiovascular Development and Disease. 2025. doi:10.3390/jcdd12090341.
BibTeX
@article{paola2025Target,
title = {Targeting Telomere Shortening in Vascular Aging and Atherosclerosis: Therapeutic Promise of Astragalus membranaceus},
author = {Paola Canale and Maria Grazia Andreassi},
journal = {Journal of Cardiovascular Development and Disease},
year = {2025},
doi = {10.3390/jcdd12090341},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Biomedicine & Pharmacotherapy 2026
Open access · CC-BY
Telomerase and chronic inflammation as central molecular links in aging
Biogerontology 2018
Citation only
Telomere and its role in the aging pathways: telomere shortening, cell senescence and mitochondria dysfunction
Experimental Gerontology 2025
Open access · CC-BY
Mesenchymal stem cells and exosomes: A novel therapeutic approach for aging
Pharmacology & Therapeutics 2015
Citation only
Telomere Dysfunction and Cell Senescence in Chronic Lung Diseases: Therapeutic Potential
Nature Cell Biology 2022
Open access · OA
Telomere dysfunction in ageing and age-related diseases
Current Opinion in Lipidology 2002
Citation only